NRIX - Nurix Therapeutics, Inc.

QQQ $ 629.25 $ -3.11 (-0.49 %)

DIA $ 472.35 $ -2.66 (-0.56 %)

SPY $ 681.43 $ -2.29 (-0.33 %)

TLT $ 89.66 $ 0.07 (0.08 %)

GLD $ 367.20 $ 0.05 (0.01 %)

Previous Close

$ 12.62

Open

$ 12.90

Bid

$ 11.25 x 5

Ask

$ 12.66 x 1

Day's Range

$ 12.28 - $ 13.19

52 Week Range

$ 8.18 - $ 29.56

Volume

2,124,670

Average Volume

Market Cap

970.27M

Beta (5Y Monthly)

$ 1.38

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-09-2025	08-31-2025	10-Q
2	07-09-2025	05-31-2025	10-Q
3	04-08-2025	02-28-2025	10-Q
4	01-28-2025	11-30-2024	10-K
5	10-11-2024	08-31-2024	10-Q
6	07-11-2024	05-31-2024	10-Q
7	04-10-2024	02-29-2024	10-Q
8	02-15-2024	11-30-2023	10-K
9	10-12-2023	08-31-2023	10-Q
10	07-13-2023	05-31-2023	10-Q
11	04-13-2023	02-28-2023	10-Q
12	02-09-2023	11-30-2022	10-K
13	10-06-2022	08-31-2022	10-Q
14	07-07-2022	05-31-2022	10-Q
15	04-08-2022	02-28-2022	10-Q
16	01-28-2022	11-30-2021	10-K
17	10-14-2021	08-31-2021	10-Q
18	07-13-2021	05-31-2021	10-Q
19	04-13-2021	02-28-2021	10-Q
20	02-16-2021	11-30-2020	10-K
21	10-14-2020	08-31-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Nurix...
10/28/2025 11:55:18

HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price targ...

Wells Fargo Maintains Overweight on Nurix ...
10/23/2025 13:16:53

Wells Fargo analyst Derek Archila maintains Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and lowers the price target f...

BTIG Maintains Buy on Nurix Therapeutics, ...
10/23/2025 09:57:31

BTIG analyst Jeet Mukherjee maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price target from $35 to $27.

Needham Maintains Buy on Nurix Therapeutic...
10/22/2025 17:45:45

Needham analyst Gil Blum maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price target from $27 to $26.

Nurix Therapeutics Prices $250M Offering O...
10/22/2025 11:23:03

Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and co...

Nurix Advances Experimental Leukemia Drug ...
10/22/2025 10:04:41

Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical stage biopharmaceutical company focused on the discovery, development, and c...

Mizuho Initiates Coverage On Nurix Therape...
10/21/2025 12:50:48

Mizuho analyst Joseph Catanzaro initiates coverage on Nurix Therapeutics (NASDAQ:NRIX) with a Outperform rating and announce...

HC Wainwright & Co. Reiterates Buy on Nuri...
10/20/2025 11:51:54

HC Wainwright & Co. analyst Robert Burns reiterates Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $33 price ...

Needham Reiterates Buy on Nurix Therapeuti...
10/20/2025 10:15:21

Needham analyst Gil Blum reiterates Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $27 price target.

Reported Saturday, Nurix's NX-1607 Achieve...
10/20/2025 08:23:02

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immu...

Morgan Stanley Maintains Equal-Weight on N...
10/14/2025 16:08:43

Morgan Stanley analyst Terence Flynn maintains Nurix Therapeutics (NASDAQ:NRIX) with a Equal-Weight and lowers the price tar...

HC Wainwright & Co. Maintains Buy on Nurix...
10/14/2025 11:22:32

HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price targ...

Breaking Down Nurix Therapeutics: 5 Analys...
10/10/2025 13:00:44

Piper Sandler Maintains Overweight on Nuri...
10/10/2025 12:55:59

Piper Sandler analyst Joseph Catanzaro maintains Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and lowers the price tar...

Oppenheimer Maintains Outperform on Nurix ...
10/10/2025 12:26:55

Oppenheimer analyst Matthew Biegler maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and lowers the price target...

nurix-therapeutics-posts-downbeat-q3-results-joins-orthopediatrics-levi-strauss-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

Nurix Therapeutics Posts Downbeat Q3 Resul...
10/10/2025 12:02:09

why-applied-digital-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket

Why Applied Digital Shares Are Trading Hig...
10/10/2025 09:06:13

levi-strauss-usana-health-sciences-and-3-stocks-to-watch-heading-into-friday

Levi Strauss, USANA Health Sciences And 3 ...
10/10/2025 06:53:44

US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.

Nurix Therapeutics Q3 EPS $(1.03) Misses $...
10/09/2025 20:03:13

Nurix And Gilead Advance IRAK4 Degrader GS...
09/17/2025 11:10:23

Nurix Therapeutics, Inc. (NASDAQ:NRIX) today announced the presentation of preclinical data from GS-6791/NX-0479, a novel IRAK4...